NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA ...

Early use of rapid sequencing markedly cut diagnostic delays and revealed more genetic conditions in children outside ...

Discover the future of genomics: Will all newborns have Whole Genome Sequencing? Explore the rapid rise of Direct to Consumer Testing and emerging technologies. Delve into global market forecasts ...

In a routine blood test that turned extraordinary, French scientists have identified the world’s newest and rarest blood ...

Scientists at the Baylor College of Medicine and collaborating institutions used complementary approaches that integrate exome sequencing and evolutionary action machine learning to identify ...

Using gene editing technology, the team confirmed their discovery by recreating the mutation in a lab. So red blood cells ...

In a routine blood test that turned extraordinary, French scientists have identified the world's newest and rarest blood ...

Overview of Genomics in Cancer Care MarketThe global Genomics in Cancer Care Market is valued at USD 24.5 Billion in 2024 and ...

GeneDx Holdings Corp (NASDAQ:WGS) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Guggenheim ...

Baylor Genetics is a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, including Whole Genome Sequencing, Whole Exome Sequencing, and focused panels.

Discover a study revealing how genetic and advanced diagnostics clarify the causes and outcomes of paediatric acute liver failure in Germany.